Real, peer-reviewed, and pointing in one direction. Environment governs who develops autoimmune disease and how severely it progresses; the disease responds to daily inputs; the science therefore points toward a daily companion.
Real, peer-reviewed, and pointing in one direction.
The immune system is mostly written by environment, not genome.
Specific environmental exposures are causal triggers of disease.
The system responds — change the inputs, the disease changes.
So the science points to a daily companion — and in being one, BuddyRise generates the evidence the field has never had. The loop closes.
This page does not claim lifestyle reverses autoimmunity. It makes a narrower, stronger claim: environment governs who develops these diseases and how severely they progress, the disease responds to daily inputs, and the science therefore points toward a daily companion — which is both what BuddyRise is and what it is built to prove.
Immune phenotype is written largely by environment, not genome — and increasingly so over a lifetime.
Systems-level analysis of 204 immune parameters across twins aged 8–82. 77% of parameters were dominated (>50% of variance) and 58% almost completely determined (>80%) by non-heritable influences. Environmental dominance increased with age, consistent with cumulative exposure.
The gut microbiome showed no significant association with genetic ancestry; host genetics played a minor role. Genetically unrelated people sharing a household had significantly similar microbiomes, and >20% of variability tracked to diet, medication, and body measures. Microbiome data improved prediction of metabolic traits beyond host genetics alone.
It is not noise. Discrete exposures cause specific diseases. The two strongest causal datasets in the field.
MS risk increased 32-fold following EBV infection — with no comparable rise after other similar viruses including cytomegalovirus. Only one of 801 MS cases was EBV-seronegative at onset. The first compelling evidence of causality in a disease long called idiopathic.
EBV is necessary but not sufficient — ~95% of adults are seropositive. A trigger, not a lever. Significance is methodological as much as biological: longitudinal data at scale resolved what decades of cross-sectional work could not.
Smoking elevates risk of ACPA-positive RA but not ACPA-negative RA. OR 5.2 for HLA shared-epitope alleles, OR 2.2 for smoking; smokers carrying SE alleles had OR 24 versus never-smokers without SE. A strong, statistically significant gene–environment interaction. Later work supports a mucosal origin of the initiating event.
A modifiable lifestyle factor interacts with genotype to cause a serologically defined subset. Autoimmune disease fractionates along environmentally defined lines.
Environment doesn't just shape the system. Alter it and the disease moves — at population scale and at the individual scale.
Incidence and prevalence of immune-mediated inflammatory disease among immigrants differ from origin populations and shift toward host-country patterns within a generation. Move a genetically stable population into a new environment, and autoimmune risk reorganizes. Environment is a primary determinant of incidence, not a marginal modifier.
A structured dietary protocol was superior to exclusive enteral nutrition for sustained remission at 12 weeks in pediatric Crohn's — diet as first-line therapy, not adjunct.
Pooled dietary intervention showed reduced fatigue and improved quality of life, with no effect on the radiological course (EDSS, MRI) and no severe adverse events.
This is a condition that answers to daily life. The bounds matter and we state them — the intervention evidence is strongest in IBD, modest in MS, and limited by small samples and short follow-up. But the direction is unambiguous: inputs move outcomes.
Dietary fiber feeds microbial production of short-chain fatty acids, which regulate the Th17/Treg balance central to autoimmune pathology via HDAC inhibition and GPCR signaling. The pathway from daily input to immune tone is biological, not correlational.
The causal work is longitudinal at the level of a diagnosis, never at the level of a day. No dataset connects daily exposures — food, sleep, stress, medication, symptoms — to disease course at scale, in real life, over years. That is the missing layer, and it cannot be bought retroactively.
~1 hour a year, episodic, no daily context.
Continuous, but no autoimmune context.
Outcomes without the inputs that moved them.
By being the intervention, BuddyRise produces the longitudinal record the field has never had: daily symptom, energy, medication and lifestyle logs, plus monthly PROMIS measures, across a growing multi-country cohort. Every day of operation is a day of record no later competitor can recover.